- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03930147
Ventilation With ASV Mode in Children
Monocentric Interventional Study on the Feasibility of the Invasive Mechanical Ventilation Mode "Adaptive Support Ventilation, ASV" in a Pediatric Population and Comparison to Pressure-Control and Pressure-Support Ventilation Modes
ASV mode of ventilation is an automatic mode with closed-loop control used for mechanical invasive ventilation in intubated patients. It has been studied in adult patients but not in children.
This interventional physiology study will include 40 children on mechanical invasive ventilation.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The objective of the study is to assess the feasibility of ASV in children and compare physiologic values on ASV mode to Pressure-Control and Pressure-Support mode of ventilation regarding the participant is on active or passive ventilation phase.
Physiologic values will be monitored on different modes of ventilation in a randomized order. Each participant will be his own control regarding the different modes of ventilation. Monitoring will be done during 90 minutes for each mode of ventilation.
Participant will have two different phases of ventilation. The first one is the passive phase (participant does not trigger the ventilator cycle sustainly) in which ASV and Pressure-Control Ventilation will be performed in a randomized order. The second phase will be the active ventilation phase (participant does trigger the ventilator cycle sustainly) in which ASV and Pressure-Support Ventilation will be performed in a randomized order.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Thomas Ferry, MD
- Phone Number: +41795563626
- Email: thomas.ferry@chuv.ch
Study Contact Backup
- Name: Marie-Helene Perez, MD
- Phone Number: +41795564082
- Email: marie-helene.perez@chuv.ch
Study Locations
-
-
-
Lausanne, Switzerland, 1011
- Lausanne University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- children on invasive mechanical ventilation admitted in the Pediatric Intensive Care Unit at Lausanne University Hospital
- Body weight > 6kg
- Absence of pulmonary comorbidity
- Age < 10 years
Exclusion Criteria:
- Patient already included in other interventional clinical study
- body weight < 6kg
- age > 10 years
- more than 20% of air leak around endotracheal tube
- chronic or acute pulmonary disease (ARDS, cystic fibrosis, severe asthma, lobectomy, severe bronchomalacia or severe tracheomalacia)
- severe pulmonary hypertension on inhaled nitric oxide treatment
- severe hemodynamic instability (more than 0.5mcg/kg/min of norepinephrine infusion or other high dose vasoactive agent infusion)
- intracranial hypertension (more than 20mmHg if measured) or suspected intracranial hypertension
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Passive phase, Pressure-Control Ventilation / ASV order
90 minutes of Pressure-Control Ventilation, change to ASV mode with 15 to 30 minutes of washout, 90 minutes of ASV.
Return to Pressure-Control Ventilation mode at the end of the intervention.
|
Ventilation on ASV mode
|
Experimental: Passive phase, ASV / Pressure-Control Ventilation order
90 minutes of ASV, change to Pressure-Control Ventilation mode with 15 to 30 minutes of washout, 90 minutes of Pressure-Control Ventilation.
|
Ventilation on ASV mode
|
Experimental: Active phase, Pressure-Support / ASV order
90 minutes of Pressure-Support Ventilation, change to ASV mode with 15 to 30 minutes of washout, 90 minutes of ASV.
Return to Pressure-Support Ventilation at the end of the intervention.
|
Ventilation on ASV mode
|
Experimental: Active phase, ASV / Pressure-Support order
90 minutes of ASV, change to Pressure-Support Ventilation with 15 to 30 minutes of washout, 90 minutes of Pressure-Support Ventilation.
|
Ventilation on ASV mode
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of respiratory rate
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Change of tidal volume
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Change of peak inspiratory pressure
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evolution of Minute Ventilation
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of Mean airway pressure
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of inspiratory time
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of ratio inspiratory time/expiratory time
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of Crs (respiratory system compliance calculated by the ventilator)
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of respiratory system resistance
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of respiratory system time constant
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of positive end expiratory pressure (PEEP)
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of the variation of respiratory rate
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of the variation of peak inspiratory pressure
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of end-tidal CO2
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of the variation of end-tidal CO2
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of transcutaneous CO2
Time Frame: Recording every 5 minutes during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Recording every 5 minutes during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of variation of transcutaneous CO2
Time Frame: Recording every 5 minutes during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Recording every 5 minutes during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of inspired oxygen fraction
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of variation of inspired oxygen fraction
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of transcutaneous oxygen saturation
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of variation of transcutaneous oxygen saturation
Time Frame: Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Physiological respiratory value of mechanical ventilation
|
Continuous recording during each monitoring phase of 90 minutes, 360 minutes
|
Evolution of the work load of mechanical ventilation for doctor
Time Frame: monitoring phase of 90 minutes
|
Recording of all modification done on ventilator parameters done by doctor during each monitoring phase
|
monitoring phase of 90 minutes
|
Evolution of mechanical ventilation tolerance
Time Frame: monitoring phase of 90 minutes
|
Recording of all sedation drugs administered to the participant during each monitoring phase
|
monitoring phase of 90 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Thomas Ferry, MD, Lausanne University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ASV ventilation in children
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mechanical Ventilation
-
Thammasat UniversityCompletedProlonged Mechanical Ventilation | Home Mechanical VentilationThailand
-
JOSE IVAN RODRIGUEZ DE MOLINA SERRANOCompletedMechanical Ventilation Complication | Mechanical Power | Driving Pressure | Lung Protective VentilationMexico
-
Academisch Medisch Centrum - Universiteit van Amsterdam...University of Zurich; Dijklander Ziekenhuis; Reinier de Graaf GroepCompletedMechanical Ventilation | Mechanical PowerNetherlands
-
Rabin Medical CenterUnknownMechanical Ventilation | Weaning | Prolonged Ventilation
-
Drägerwerk AG & Co. KGaAUniversity of Göttingen; Prof. Dr. med. ImhoffSuspendedMechanical Ventilation | Ventilation Perfusion MismatchGermany
-
Capital Medical UniversityRecruitingMechanical VentilationChina
-
University of ChicagoActive, not recruitingMechanical VentilationUnited States
-
Chang Gung UniversityCompleted
-
The University of Texas Health Science Center,...Edwards LifesciencesWithdrawnMechanical VentilationUnited States
-
Bursa Yüksek İhtisas Education and Research HospitalCompletedthe Effect of Different Mechanical Ventilation Modes on Optic Nerve Diameter and Conscious FunctionsMechanical VentilationTurkey
Clinical Trials on ASV ventilation
-
University of ZurichCompletedAcute Respiratory Distress Syndrome | Cardiogenic Shock
-
Beth Israel Deaconess Medical CenterCompletedAcute Respiratory Distress SyndromeUnited States
-
Prof. Dr. Marcus J. SchultzCatharina Ziekenhuis Eindhoven; Academisch Medisch Centrum - Universiteit van... and other collaboratorsRecruitingVentilator-free Days | Quality of BreathingNetherlands, Italy
-
Postgraduate Institute of Medical Education and...CompletedChronic Obstructive Pulmonary Disease | Invasive Mechanical Ventilation | Adaptive Support VentilationIndia
-
Cliniques universitaires Saint-Luc- Université...CompletedAcute Mechanical Ventilatory Failure | Psychosis Associated With Intensive CareBelgium
-
University Hospital RegensburgResMed FoundationTerminatedSleep Apnea | Acute Myocardial InfarctionGermany
-
Academisch Medisch Centrum - Universiteit van Amsterdam...University of Zurich; Dijklander Ziekenhuis; Reinier de Graaf GroepCompletedMechanical Ventilation | Mechanical PowerNetherlands
-
ResMedTerminatedDiastolic Heart FailureGermany
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Hamilton Medical AGTerminated
-
Toronto Rehabilitation InstituteCanadian Institutes of Health Research (CIHR); Philips RespironicsTerminatedHeart Failure | Sleep ApneaCanada, Spain, Japan, Germany, France, United States, Brazil, Italy, United Kingdom